Clinical Trials Directory

Trials / Unknown

UnknownNCT01905748

Acute Phase Reactions and Thrombophilia in Pediatric Patients With Migraine

Acute Phase Reactions and Thrombophilia in Pediatric Patients With Migraine, Laboratory Investigations in Steady State and During Migraine Attack

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
15 (estimated)
Sponsor
HaEmek Medical Center, Israel · Academic / Other
Sex
All
Age
5 Years – 20 Years
Healthy volunteers
Not accepted

Summary

Acute Migraine attacks can be related to vascular or coagulation activation. Previous studies found relative high incidence of prothrombotic events in Migraine. The present study intends to assess the coagulation system and activation in patients with Migraine during steady state phase and at the beginning of attacks and after 72 hours. A control group of patients with another acute neurologic event like convulsions will be also studied. Patients will be at pediatric age and teenagers.

Conditions

Interventions

TypeNameDescription
OTHERLaboratory testsLaboratory tests: erythrocyte sedimentation rate (ESR), Blood Count, C reactive Protein, Protein C activity, Protein S activity,Antithrombin II activity, Coagulation Factor VIII and IX,Con Willebrand Factor, prothrombin time (PT), activated partial thromboplastin time (aPTT), Fibrinogen, D Dimer and Prothrombin Fragments F1 and F2.

Timeline

Start date
2011-08-01
Primary completion
2020-12-31
Completion
2020-12-31
First posted
2013-07-23
Last updated
2019-10-31

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01905748. Inclusion in this directory is not an endorsement.

Acute Phase Reactions and Thrombophilia in Pediatric Patients With Migraine (NCT01905748) · Clinical Trials Directory